You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
港股異動丨中藥股拉昇 世衞組織鼓勵成員國考慮吸納中醫藥治療新冠
格隆匯4月6日丨港股市場中國中藥大漲7.57%,現代中藥集團漲逾3%;A股市場上海凱寶漲逾11%,大理藥業和以嶺藥業漲停。“世界衞生組織關於中醫藥治療新冠肺炎專家評估會”的報吿於3月31日在世衞組織官網發佈,來自世衞組織6個區域的21名國際專家參加了評估會,會議報吿指出:中藥能有效治療新冠肺炎,降低輕型、普通型病例轉為重症,縮短病毒清除時間,改善輕型和普通型患者的臨牀預後。報吿同時鼓勵成員國考慮中國形成並應用的整合醫學模式(中西醫結合模式);有效管理當前疫情並對未來可能發生的大流行做好準備。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account